About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

Medical Innovation - Changing Business Models

A Joint Technical Symposium by WHO, WIPO and WTO

Geneva, July 5, 2013 (WIPO, 34, chemin des Colombettes - Room A)

The World Health Organization (WHO), World Intellectual Property Organization (WIPO) and World Trade Organization (WTO) will hold a technical symposium on “Medical Innovation – Changing Business Models” on 5 July, 2013 at the World Intellectual Property Organization in Geneva. The purpose of the third trilateral joint technical Symposium is to discuss current changes in the innovation landscape and explore new and potential business models in medical innovation.

Participants are expected to be Geneva-based delegations to the WHO, WIPO and WTO, representatives of international and philanthropic organizations, experts on patent information, civil society organizations and all interested individuals and organizations.

Please note that the Symposium will be held in English only; no interpretation will be available. Participation is open to all interested individuals and organizations, subject to availability of space.  E-mails requesting registration should include the participant's name, position and affiliation together with full contact details. Registered participants without UN or WTO accreditation need to bring official identification.

Background

The conventional innovation model for medical research and development (R&D) is facing a number of challenges with respect to the way innovation is financed and carried out. Collaborative innovation models, new industry structures, evolving market requirements, emerging markets, and public health needs in developed and developing countries require careful scrutiny of innovation policies. They result in evolving cooperation landscapes involving different sectors and areas of the world.

More recently, the pharmaceutical industry has witnessed some important changes: Companies merge in order to strengthen innovative capacities, and acquisitions of generic companies by originator companies, and vice versa, blur the traditional boundary between R&D based industry and generic medicine makers. In parallel, a development of differentiation and work sharing can be observed, for example in the field of biotechnology in which often small and medium size biotechnology companies, including start-up companies, or universities do basic or specialized research, sometimes in cooperation with, or funded by industry, and license out the R&D results to the pharmaceutical industry. At the same time, public sector research continues to contribute to providing direct research and development outputs. This development is supported by national legislation encouraging universities to actively manage their research outcomes, particularly also through intellectual property licensing, and leading to increased cooperation with the private sector in public private and product development partnerships.

The recognition that reliance on market mechanisms alone does not always work to achieve outcomes, namely where markets are small and do not promise sufficient yields, prompted the search for, and establishment of new forms of cooperation and partnership with the goal to obtain results and improvement for those situations. Such projects related to both addressing the economic challenges of research, development and production for small markets and the use, benefits and limitations of intellectual property and intellectual property management in this context. In parallel, new and additional schemes to support the endeavor of innovation incentives have been developed, such as advanced market commitments, grants, prizes, and tax incentives and the emergence of the overarching concept of de-linking the price of medical products from the costs of research. In addition, a broad range of ideas how to better support and finance R&D is being discussed by key stakeholders in different fora.

The Symposium is the third in the series of joint technical symposia on public health, intellectual property and trade convened by the WHO, WIPO and the WTO. It builds on the collaborative work undertaken by the three agencies to enhance capacity, including in the form of the recent publication Promoting Access to Medical Technologies and Innovation.

The study and information about the previous symposia are available on the websites of the WHO, WIPO, and WTO.

Quick Links